Selected research
Industry Research
API CDMO+CMC Service Platform Industry Research Report 2026
Market perspective
The global API CDMO+CMC Service Platform market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
North America: the API CDMO+CMC Service Platform market is projected to increase from US$ million in 2026 to US$ million by 2032, reflecting a CAGR of % over 2026–2032. Europe: the API CDMO+CMC Service Platform market is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032. Asia Pacific: the API CDMO+CMC Service Platform market is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032. Leading global service providers of API CDMO+CMC Service Platform include Lonza Group, Catalent, Inc., Thermo Fisher Scientific, Pfizer CentreOne, CordenPharma International, Boehringer Ingelheim BioXcellence, Recipharm AB, Changsha Jingyi Pharmaceutical Technology Co., Ltd. and GlaxoSmithKline, among others; in 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
Read the full market overview
This report quantifies the global API CDMO+CMC Service Platform market in terms of revenue (US$ million) and, where applicable, service volume (k units), using 2024 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of service Types and end-use Applications, harmonizes provider attribution, and delivers comparable time series by company, Type, Application, and region or country, including indicative price bands (US$/k units) and concentration ratios (CR5/CR10). Outputs are intended to support service design, budgeting, capacity planning, and benchmarking for providers, platforms, channel partners, and investors; the report also reviews technology shifts and notable service innovations relevant to API CDMO+CMC Service Platform.
Key Companies & Market Share Insights
This section profiles leading service providers with 2021–2025 results and a 2026–2032 outlook—covering revenue, market share, price bands, service portfolio and client mix, regional and channel mix, and key developments (M&A, network expansion, certifications). It also provides global revenue, average price, and—where applicable—volume metrics by provider, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
API CDMO+CMC Service Platform Market by Company
Lonza Group
Catalent, Inc.
Thermo Fisher Scientific
Pfizer CentreOne
CordenPharma International
Boehringer Ingelheim BioXcellence
Recipharm AB
Changsha Jingyi Pharmaceutical Technology Co., Ltd.
GlaxoSmithKline
Samsung BioLogics
Emergent BioSolutions
API CDMO+CMC Service Platform Segment by Type
Comprehensive CDMO Platform
Professional CDMO Platform
International CDMO Platform
API CDMO+CMC Service Platform Segment by Application
New Drug Development
Clinical Stage Production
Commercial Production
API CDMO+CMC Service Platform Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Spain
Russia
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Colombia
Middle East & Africa
Saudi Arabia
Israel
United Arab Emirates
Turkey
Iran
Egypt
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global API CDMO+CMC Service Platform market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of API CDMO+CMC Service Platform and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of API CDMO+CMC Service Platform.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 6: Detailed analysis of API CDMO+CMC Service Platform companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, South America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 13: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Comprehensive CDMO Platform
- Professional CDMO Platform
- International CDMO Platform
Applications
- New Drug Development
- Clinical Stage Production
- Commercial Production
Companies covered
- Lonza Group
- Catalent, Inc.
- Thermo Fisher Scientific
- Pfizer CentreOne
- CordenPharma International
- Boehringer Ingelheim BioXcellence
- Recipharm AB
- Changsha Jingyi Pharmaceutical Technology Co., Ltd.
- GlaxoSmithKline
- Samsung BioLogics
- Emergent BioSolutions
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 API CDMO+CMC Service Platform by Type
- 2.2.1 Market Value Comparison by Type (2021 VS 2025 VS 2032)
- 2.2.2 Comprehensive CDMO Platform
- 2.2.3 Professional CDMO Platform
- 2.2.4 International CDMO Platform
- 2.3 API CDMO+CMC Service Platform by Application
- 2.3.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.3.2 New Drug Development
- 2.3.3 Clinical Stage Production
- 2.3.4 Commercial Production
- 2.4 Assumptions and Limitations
3 API CDMO+CMC Service Platform Breakdown Data by Type
- 3.1 Global API CDMO+CMC Service Platform Historic Market Size by Type (2021-2026)
- 3.2 Global API CDMO+CMC Service Platform Forecasted Market Size by Type (2027-2032)
4 API CDMO+CMC Service Platform Breakdown Data by Application
- 4.1 Global API CDMO+CMC Service Platform Historic Market Size by Application (2021-2026)
- 4.2 Global API CDMO+CMC Service Platform Forecasted Market Size by Application (2027-2032)
5 Global Growth Trends
- 5.1 Global API CDMO+CMC Service Platform Market Perspective (2021-2032)
- 5.2 Global API CDMO+CMC Service Platform Growth Trends by Region
- 5.2.1 Global API CDMO+CMC Service Platform Market Size by Region: 2021 VS 2025 VS 2032
- 5.2.2 API CDMO+CMC Service Platform Historic Market Size by Region (2021-2026)
- 5.2.3 API CDMO+CMC Service Platform Forecasted Market Size by Region (2027-2032)
- 5.3 API CDMO+CMC Service Platform Market Dynamics
- 5.3.1 API CDMO+CMC Service Platform Industry Trends
- 5.3.2 API CDMO+CMC Service Platform Market Drivers
- 5.3.3 API CDMO+CMC Service Platform Market Challenges
- 5.3.4 API CDMO+CMC Service Platform Market Restraints
6 Market Competitive Landscape by Players
- 6.1 Global Top API CDMO+CMC Service Platform Players by Revenue
- 6.1.1 Global Top API CDMO+CMC Service Platform Players by Revenue (2021-2026)
- 6.1.2 Global API CDMO+CMC Service Platform Revenue Market Share by Players (2021-2026)
- 6.2 Global API CDMO+CMC Service Platform Industry Players Ranking, 2023 VS 2024 VS 2025
- 6.3 Global Key Players of API CDMO+CMC Service Platform Head Office and Area Served
- 6.4 Global API CDMO+CMC Service Platform Players, Product Type & Application
- 6.5 Global API CDMO+CMC Service Platform Manufacturers Established Date
- 6.6 Global API CDMO+CMC Service Platform Market CR5 and HHI
- 6.7 Global Players Mergers & Acquisition
7 North America
- 7.1 North America API CDMO+CMC Service Platform Market Size (2021-2032)
- 7.2 North America API CDMO+CMC Service Platform Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 7.3 North America API CDMO+CMC Service Platform Market Size by Country (2021-2026)
- 7.4 North America API CDMO+CMC Service Platform Market Size by Country (2027-2032)
- 7.5 United States
- 7.5 United States
- 7.6 Canada
- 7.7 Mexico
8 Europe
- 8.1 Europe API CDMO+CMC Service Platform Market Size (2021-2032)
- 8.2 Europe API CDMO+CMC Service Platform Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.3 Europe API CDMO+CMC Service Platform Market Size by Country (2021-2026)
- 8.4 Europe API CDMO+CMC Service Platform Market Size by Country (2027-2032)
- 8.5 Germany
- 8.6 France
- 8.7 U.K.
- 8.8 Italy
- 8.9 Spain
- 8.10 Russia
- 8.11 Netherlands
- 8.12 Nordic Countries
9 Asia-Pacific
- 9.1 Asia-Pacific API CDMO+CMC Service Platform Market Size (2021-2032)
- 9.2 Asia-Pacific API CDMO+CMC Service Platform Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 9.3 Asia-Pacific API CDMO+CMC Service Platform Market Size by Country (2021-2026)
- 9.4 Asia-Pacific API CDMO+CMC Service Platform Market Size by Country (2027-2032)
- 9.5 China
- 9.6 Japan
- 9.7 South Korea
- 9.8 India
- 9.9 Australia
- 9.10 China Taiwan
- 9.11 Southeast Asia
10 South America
- 10.1 South America API CDMO+CMC Service Platform Market Size (2021-2032)
- 10.2 South America API CDMO+CMC Service Platform Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 10.3 South America API CDMO+CMC Service Platform Market Size by Country (2021-2026)
- 10.4 South America API CDMO+CMC Service Platform Market Size by Country (2027-2032)
- 10.5 Brazil
- 10.6 Argentina
- 10.7 Chile
- 10.8 Colombia
- 10.9 Peru
11 Middle East & Africa
- 11.1 Middle East & Africa API CDMO+CMC Service Platform Market Size (2021-2032)
- 11.2 Middle East & Africa API CDMO+CMC Service Platform Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 11.3 Middle East & Africa API CDMO+CMC Service Platform Market Size by Country (2021-2026)
- 11.4 Middle East & Africa API CDMO+CMC Service Platform Market Size by Country (2027-2032)
- 11.5 Saudi Arabia
- 11.6 Israel
- 11.7 United Arab Emirates
- 11.8 Turkey
- 11.9 Iran
- 11.10 Egypt
12 Players Profiled
- 12.1 Lonza Group
- 12.1.1 Lonza Group Company Information
- 12.1.2 Lonza Group Business Overview
- 12.1.3 Lonza Group Revenue in API CDMO+CMC Service Platform Business (2021-2026)
- 12.1.4 Lonza Group API CDMO+CMC Service Platform Product Portfolio
- 12.1.5 Lonza Group Recent Developments
- 12.2 Catalent, Inc.
- 12.2.1 Catalent, Inc. Company Information
- 12.2.2 Catalent, Inc. Business Overview
- 12.2.3 Catalent, Inc. Revenue in API CDMO+CMC Service Platform Business (2021-2026)
- 12.2.4 Catalent, Inc. API CDMO+CMC Service Platform Product Portfolio
- 12.2.5 Catalent, Inc. Recent Developments
- 12.3 Thermo Fisher Scientific
- 12.3.1 Thermo Fisher Scientific Company Information
- 12.3.2 Thermo Fisher Scientific Business Overview
- 12.3.3 Thermo Fisher Scientific Revenue in API CDMO+CMC Service Platform Business (2021-2026)
- 12.3.4 Thermo Fisher Scientific API CDMO+CMC Service Platform Product Portfolio
- 12.3.5 Thermo Fisher Scientific Recent Developments
- 12.4 Pfizer CentreOne
- 12.4.1 Pfizer CentreOne Company Information
- 12.4.2 Pfizer CentreOne Business Overview
- 12.4.3 Pfizer CentreOne Revenue in API CDMO+CMC Service Platform Business (2021-2026)
- 12.4.4 Pfizer CentreOne API CDMO+CMC Service Platform Product Portfolio
- 12.4.5 Pfizer CentreOne Recent Developments
- 12.5 CordenPharma International
- 12.5.1 CordenPharma International Company Information
- 12.5.2 CordenPharma International Business Overview
- 12.5.3 CordenPharma International Revenue in API CDMO+CMC Service Platform Business (2021-2026)
- 12.5.4 CordenPharma International API CDMO+CMC Service Platform Product Portfolio
- 12.5.5 CordenPharma International Recent Developments
- 12.6 Boehringer Ingelheim BioXcellence
- 12.6.1 Boehringer Ingelheim BioXcellence Company Information
- 12.6.2 Boehringer Ingelheim BioXcellence Business Overview
- 12.6.3 Boehringer Ingelheim BioXcellence Revenue in API CDMO+CMC Service Platform Business (2021-2026)
- 12.6.4 Boehringer Ingelheim BioXcellence API CDMO+CMC Service Platform Product Portfolio
- 12.6.5 Boehringer Ingelheim BioXcellence Recent Developments
- 12.7 Recipharm AB
- 12.7.1 Recipharm AB Company Information
- 12.7.2 Recipharm AB Business Overview
- 12.7.3 Recipharm AB Revenue in API CDMO+CMC Service Platform Business (2021-2026)
- 12.7.4 Recipharm AB API CDMO+CMC Service Platform Product Portfolio
- 12.7.5 Recipharm AB Recent Developments
- 12.8 Changsha Jingyi Pharmaceutical Technology Co., Ltd.
- 12.8.1 Changsha Jingyi Pharmaceutical Technology Co., Ltd. Company Information
- 12.8.2 Changsha Jingyi Pharmaceutical Technology Co., Ltd. Business Overview
- 12.8.3 Changsha Jingyi Pharmaceutical Technology Co., Ltd. Revenue in API CDMO+CMC Service Platform Business (2021-2026)
- 12.8.4 Changsha Jingyi Pharmaceutical Technology Co., Ltd. API CDMO+CMC Service Platform Product Portfolio
- 12.8.5 Changsha Jingyi Pharmaceutical Technology Co., Ltd. Recent Developments
- 12.9 GlaxoSmithKline
- 12.9.1 GlaxoSmithKline Company Information
- 12.9.2 GlaxoSmithKline Business Overview
- 12.9.3 GlaxoSmithKline Revenue in API CDMO+CMC Service Platform Business (2021-2026)
- 12.9.4 GlaxoSmithKline API CDMO+CMC Service Platform Product Portfolio
- 12.9.5 GlaxoSmithKline Recent Developments
- 12.10 Samsung BioLogics
- 12.10.1 Samsung BioLogics Company Information
- 12.10.2 Samsung BioLogics Business Overview
- 12.10.3 Samsung BioLogics Revenue in API CDMO+CMC Service Platform Business (2021-2026)
- 12.10.4 Samsung BioLogics API CDMO+CMC Service Platform Product Portfolio
- 12.10.5 Samsung BioLogics Recent Developments
- 12.11 Emergent BioSolutions
- 12.11.1 Emergent BioSolutions Company Information
- 12.11.2 Emergent BioSolutions Business Overview
- 12.11.3 Emergent BioSolutions Revenue in API CDMO+CMC Service Platform Business (2021-2026)
- 12.11.4 Emergent BioSolutions API CDMO+CMC Service Platform Product Portfolio
- 12.11.5 Emergent BioSolutions Recent Developments
13 Report Conclusion
14 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst